Lutris Pharma

Tel Aviv, Israel · Founded 2016 · $30.0M raised

Headquarters
Tel Aviv
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$30.0M
Last Round
$30.0M Series AJan 2025
Rounds
2

About

Lutris Pharma is a Tel Aviv-based clinical-stage biopharmaceutical company focused on improving the effectiveness and tolerability of anti-cancer therapies. The company develops proprietary treatments designed to reduce the dermatological side effects — such as skin toxicity — that commonly limit dosing and quality of life for oncology patients receiving targeted cancer therapies. Lutris raised $30 million in financing to advance its lead biopharmaceutical program through clinical development.

Summary

Lutris Pharma is a Biotech company based in Tel Aviv, Israel, founded in 2016. It has raised $30.0M in total across 2 rounds, most recently a $30.0M Series A round in Jan 2025. Investors include Pontifax, Columbus Venture Partners and Peregrine Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2025
$30.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Lutris Pharma on Indexed.vc
<a href="https://indexed.vc/companies/lutris-pharma"><img src="https://indexed.vc/api/badge/company/lutris-pharma" alt="Lutris Pharma on Indexed.vc" width="260" height="76" /></a>